Disorder of Localized Inflammation in Wound Healing: A Systems Perspective

  • Sashwati Roy
  • Amitava Das
  • Chandan K. Sen


Wound healing is a well-coordinated concerted event in response to injury and its microenvironment, which aims at reinstating normal tissue homeostasis. Being a well-organized reparative biological event, it comprises of a cascade of events, which takes place in a sequential overlapping manner. Reductionism, as a guiding principle, is of great value where a quick and effective solution is required for an isolated problem. Reductionism is less helpful for complex systems such as the process of wound healing where interactions between components decides the final outcome and dysregulation of just one of the components can result in malfunctioning of the entire system. A comprehensive approach is necessary to understand the dynamics and interplay between various components, which shape the fate of the outcome towards a healing or a nonhealing wound. The current review highlights the multidimensional nature of the deregulation of diabetic wound inflammation, making it essential to understand the problems from systems perspective and not in a reductionist approach.


Wound Healing Chronic Wound Inflammatory Phase Diabetic Wound Diabetic Foot Ulceration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sen CK (2009) Wound healing essentials: let there be oxygen. Wound Repair Regen 17:1–18PubMedCrossRefGoogle Scholar
  2. 2.
    Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738–746PubMedCrossRefGoogle Scholar
  3. 3.
    Falanga V (2004) The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cells Mol Dis 32:88–94PubMedCrossRefGoogle Scholar
  4. 4.
    Martin P (1997) Wound healing – aiming for perfect skin regeneration. Science 276:75–81PubMedCrossRefGoogle Scholar
  5. 5.
    Broughton G 2nd, Janis JE, Attinger CE (2006) Wound healing: an overview. Plast Reconstr Surg 117:1e-S–32e-SGoogle Scholar
  6. 6.
    Rodriguez-Vita J, Lawrence T (2010) The resolution of inflammation and cancer. Cytokine Growth Factor Rev 21:61–65PubMedCrossRefGoogle Scholar
  7. 7.
    Gillitzer R, Goebeler M (2001) Chemokines in cutaneous wound healing. J Leukoc Biol 69:513–521PubMedGoogle Scholar
  8. 8.
    Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF (2007) Impaired wound healing. Clin Dermatol 25:19–25PubMedCrossRefGoogle Scholar
  9. 9.
    ADA (2004) Tests of glycemia in diabetes. Diabetes Care 27:S91–S93CrossRefGoogle Scholar
  10. 10.
    Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22:382–387PubMedCrossRefGoogle Scholar
  11. 11.
    Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115:245–253PubMedCrossRefGoogle Scholar
  12. 12.
    Fahey TJ 3rd, Sadaty A, Jones WG 2nd, Barber A, Smoller B, Shires GT (1991) Diabetes impairs the late inflammatory response to wound healing. J Surg Res 50:308–313PubMedCrossRefGoogle Scholar
  13. 13.
    Oberyszyn TM (2007) Inflammation and wound healing. Front Biosci 12:2993–2999PubMedCrossRefGoogle Scholar
  14. 14.
    Ferreiro JL, Gomez-Hospital JA, Angiolillo DJ (2010) Platelet abnormalities in diabetes mellitus. Diab Vasc Dis Res 7:251–259PubMedCrossRefGoogle Scholar
  15. 15.
    Dovi JV, He LK, DiPietro LA (2003) Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 73:448–455PubMedCrossRefGoogle Scholar
  16. 16.
    Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15:599–607PubMedCrossRefGoogle Scholar
  17. 17.
    Daley JM, Reichner JS, Mahoney EJ, Manfield L, Henry WL Jr, Mastrofrancesco B, Albina JE (2005) Modulation of macrophage phenotype by soluble product(s) released from neutrophils. J Immunol 174:2265–2272PubMedGoogle Scholar
  18. 18.
    Hatanaka E, Monteagudo PT, Marrocos MS, Campa A (2006) Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 146:443–447PubMedCrossRefGoogle Scholar
  19. 19.
    Ambrosch A, Haefner S, Jude E, Lobmann R (2011) Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant staphylococcus aureus. Int Wound J 8:567–577PubMedCrossRefGoogle Scholar
  20. 20.
    Hanses F, Park S, Rich J, Lee JC (2011) Reduced neutrophil apoptosis in diabetic mice during staphylococcal infection leads to prolonged tnfalpha production and reduced neutrophil clearance. PLoS One 6:e23633PubMedCrossRefGoogle Scholar
  21. 21.
    Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, Sannomiya P (2007) Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 40:1037–1044PubMedCrossRefGoogle Scholar
  22. 22.
    Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127:514–525PubMedCrossRefGoogle Scholar
  23. 23.
    Rappolee DA, Mark D, Banda MJ, Werb Z (1988) Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 241:708–712PubMedCrossRefGoogle Scholar
  24. 24.
    Leibovich SJ, Ross R (1975) The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 78:71–100PubMedGoogle Scholar
  25. 25.
    Goren I, Allmann N, Yogev N, Schurmann C, Linke A, Holdener M, Waisman A, Pfeilschifter J, Frank S (2009) A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme m-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol 175:132–147PubMedCrossRefGoogle Scholar
  26. 26.
    Mirza R, DiPietro LA, Koh TJ (2009) Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 175:2454–2462PubMedCrossRefGoogle Scholar
  27. 27.
    Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, Bhasker V, Gordillo GM, Sen CK, Roy S (2010) Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 5:e9539PubMedCrossRefGoogle Scholar
  28. 28.
    Glass EJ, Stewart J, Weir DM (1986) Altered immune function in alloxan-induced diabetes in mice. Clin Exp Immunol 65:614–621PubMedGoogle Scholar
  29. 29.
    Glass EJ, Stewart J, Matthews DM, Collier A, Clarke BF, Weir DM (1987) Impairment of monocyte “lectin-like” receptor activity in type 1 (insulin-dependent) diabetic patients. Diabetologia 30:228–231PubMedCrossRefGoogle Scholar
  30. 30.
    O’Brien BA, Fieldus WE, Field CJ, Finegood DT (2002) Clearance of apoptotic beta-cells is reduced in neonatal autoimmune diabetes-prone rats. Cell Death Differ 9:457–464PubMedCrossRefGoogle Scholar
  31. 31.
    Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176:287–292PubMedCrossRefGoogle Scholar
  32. 32.
    Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181:3733–3739PubMedGoogle Scholar
  33. 33.
    Brancato SK, Albina JE (2011) Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol 178:19–25PubMedCrossRefGoogle Scholar
  34. 34.
    Bories G, Caiazzo R, Derudas B, Copin C, Raverdy V, Pigeyre M, Pattou F, Staels B, Chinetti-Gbaguidi G (2012) Impaired alternative macrophage differentiation of peripheral blood mononuclear cells from obese subjects. Diab Vasc Dis Res 9:189–195PubMedCrossRefGoogle Scholar
  35. 35.
    Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835–870PubMedGoogle Scholar
  36. 36.
    Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI (2000) Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 14:2525–2531PubMedCrossRefGoogle Scholar
  37. 37.
    Sander AL, Henrich D, Muth CM, Marzi I, Barker JH, Frank JM (2009) In vivo effect of hyperbaric oxygen on wound angiogenesis and epithelialization. Wound Repair Regen 17: 179–184PubMedCrossRefGoogle Scholar
  38. 38.
    Mooney DP, O’Reilly M, Gamelli RL (1990) Tumor necrosis factor and wound healing. Ann Surg 211:124–129PubMedCrossRefGoogle Scholar
  39. 39.
    Goren I, Muller E, Schiefelbein D, Christen U, Pfeilschifter J, Muhl H, Frank S (2007) Systemic anti-tnfalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 127:2259–2267PubMedCrossRefGoogle Scholar
  40. 40.
    Shinozaki M, Okada Y, Kitano A, Ikeda K, Saika S (2009) Impaired cutaneous wound healing with excess granulation tissue formation in tnfalpha-null mice. Arch Dermatol Res 301:531–537PubMedCrossRefGoogle Scholar
  41. 41.
    Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765PubMedCrossRefGoogle Scholar
  42. 42.
    Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808PubMedGoogle Scholar
  43. 43.
    Gronert K (2008) Lipid autacoids in inflammation and injury responses: a matter of privilege. Mol Interv 8:28–35PubMedCrossRefGoogle Scholar
  44. 44.
    Haeggstrom JZ, Rinaldo-Matthis A, Wheelock CE, Wetterholm A (2010) Advances in eicosanoid research, novel therapeutic implications. Biochem Biophys Res Commun 396:135–139PubMedCrossRefGoogle Scholar
  45. 45.
    Broughton G 2nd, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117:12S–34SPubMedCrossRefGoogle Scholar
  46. 46.
    Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612–619PubMedCrossRefGoogle Scholar
  47. 47.
    Maddox JF, Serhan CN (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 183:137–146PubMedCrossRefGoogle Scholar
  48. 48.
    Jozsef L, Zouki C, Petasis NA, Serhan CN, Filep JG (2002) Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA 99:13266–13271PubMedCrossRefGoogle Scholar
  49. 49.
    Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192:1197–1204PubMedCrossRefGoogle Scholar
  50. 50.
    Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 206:15–23PubMedCrossRefGoogle Scholar
  51. 51.
    Horrillo R, Gonzalez-Periz A, Martinez-Clemente M, Lopez-Parra M, Ferre N, Titos E, Moran-Salvador E, Deulofeu R, Arroyo V, Claria J (2010) 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J Immunol 184:3978–3987PubMedCrossRefGoogle Scholar
  52. 52.
    Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, Claria J (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23:1946–1957PubMedCrossRefGoogle Scholar
  53. 53.
    Hellmann J, Tang Y, Spite M (2012) Proresolving lipid mediators and diabetic wound healing. Curr Opin Endocrinol Diabetes Obes 19:104–108PubMedGoogle Scholar
  54. 54.
    Sen CK, Roy S (2007) miRNA: licensed to kill the messenger. DNA Cell Biol 26:193–194PubMedCrossRefGoogle Scholar
  55. 55.
    Banerjee J, Chan YC, Sen CK (2011) Micrornas in skin and wound healing. Physiol Genomics 43:543–556PubMedCrossRefGoogle Scholar
  56. 56.
    Biswas S, Roy S, Banerjee J, Hussain SR, Khanna S, Meenakshisundaram G, Kuppusamy P, Friedman A, Sen CK (2010) Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci USA 107:6976–6981PubMedCrossRefGoogle Scholar
  57. 57.
    Shilo S, Roy S, Khanna S, Sen CK (2007) Microrna in cutaneous wound healing: a new paradigm. DNA Cell Biol 26:227–237PubMedCrossRefGoogle Scholar
  58. 58.
    Shilo S, Roy S, Khanna S, Sen CK (2008) Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol 28:471–477PubMedCrossRefGoogle Scholar
  59. 59.
    Roy S, Sen CK (2011) Mirna in innate immune responses: novel players in wound inflammation. Physiol Genomics 43:557–565PubMedCrossRefGoogle Scholar
  60. 60.
    Recchiuti A, Krishnamoorthy S, Fredman G, Chiang N, Serhan CN (2011) MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-mirna circuits. FASEB J 25:544–560PubMedCrossRefGoogle Scholar
  61. 61.
    Xu J, Wu W, Zhang L, Dorset-Martin W, Morris MW, Mitchell ME, Liechty KW (2012) The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment. Diabetes 61:2906–2912PubMedCrossRefGoogle Scholar
  62. 62.
    Madhyastha R, Madhyastha H, Nakajima Y, Omura S, Maruyama M (2012) MicroRNA signature in diabetic wound healing: promotive role of miR-21 in fibroblast migration. Int Wound J 9:355–361PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Comprehensive Wound Center, Department of Surgery, Davis Heart & Lung Research InstituteThe Ohio State University Wexner Medical CenterColumbusUSA

Personalised recommendations